Retatrutide: How It Works and What the Research Shows
Retatrutide is the most powerful weight-management molecule in development. In early trials it produced the highest weight-loss figures ever recorded for this class. Here is how it works and what the research shows.
How retatrutide works
Retatrutide is a triple agonist. On top of the GLP-1 and GIP receptors that tirzepatide hits, it adds a third target, glucagon, which raises energy expenditure alongside appetite control.
What the research shows
A Phase 2 trial published in the New England Journal of Medicine recorded up to roughly 24 percent body-weight loss, the highest of any compound in the class so far. The trade-off: it is not approved yet, so it sits at the cutting edge of research rather than the proven mainstream.
Where it fits
Retatrutide is for those tracking the frontier who accept that it is unproven. It is the strongest on paper. For the strongest option that is already approved, see tirzepatide.
Sourcing verified Retatrutide
Quality varies widely between sellers. Every Purivial Retatrutide vial ships with a batch-specific COA showing HPLC purity of 99 percent or higher and mass-spec identity, so you know what is in the vial before it leaves the lab.
FAQ
Is retatrutide stronger than tirzepatide?
In trials it showed higher weight loss, but it is still Phase 3 and not approved, while tirzepatide is approved.
Is retatrutide approved?
No. It is in Phase 3 trials, which is why research vendors are the only current route.
What vial sizes does Purivial carry?
From 5 mg up to 30 mg, each with a batch-specific COA.
Related: How Purivial verifies every batch · All guides